Moberg Pharma (Sweden)

In Vitro Terbinafine Susceptibility of Dermatophytes and Mycological Cure Outcomes from a Multicenter Phase III Onychomycosis Trial

Background: Dermatophyte infections, including onychomycosis, affect millions worldwide. Terbinafine, an allylamine antifungal, remains a foundational method of treatment. Objective: We aim to evaluate the in vitro antifungal susceptibility of terbinafine against dermatophyte iso...